Latest Updates on XBI
-
Stocks How to Profit in a $29 Billion “New Biotech” Sector
Back in the late 1960s and early 1970s, psychedelics drugs like LSD were still legal and could be researched.But in 1968 when the federal government criminalized them, a lot of promising research stopped.Now the spotlight is back on … Read more » -
Cannabis There's Still Some Time to Move on This Must-Own Biotech
Some market-leading biotech firms are working hard right now developing drugs derived from cannabis' many beneficial compounds.And there's one innovative company that puts you right in the middle of the sector's market-crushing … Read more » -
Biotechnology Instead of Chasing Every New Vaccine "Breakthrough," Trade the Whole Sector
Not every biotech company is doing well in the search for an effective COVID-19 vaccine or treatment.And the latest firm to struggle is Eli Lilly, whose antibody clinical trial was paused due to failure to show any real results.So … Read more » -
Dow Jones The Dow Jones Today Will Lose Hundreds of Points as China Raises Tariffs
The Dow Jones today will plummet as China plans its own tariff hike on $60 billion of U.S. goods starting June 1. This is the latest intensification of a trade war between the countries. Read more » -
Biotechnology Let's Buy the Real Breakout in the Soaring Tech Sector
The tech sector has been having a field day lately, and our Chris Johnson is back with his latest "Best in Breed" focus: biotech. Read more » -
Stocks The 3 Best Biotech Stocks to Buy for 2018
Investors looking for profits in the healthcare sector had a difficult time in 2017 if they weren't in biotech. The Health Care SPDR ETF only gained 13.15% last year, while the S&P 500 climbed 22.5% over the same time period. But within … Read more » -
etfs Best ETF Performers of the Week (June 19-23, 2017)
Here's a look at the best ETF performers for the week of June 19-23, 2017. Biotech dominated the list, with four of the top 10 performers. Read more »
